<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=213807269037206&ev=PageView&noscript=1">
IMARC Blog

Compliance In Focus

FILTER BY:

Newest Post

Posted by John Lehmann on Tue, Jul 05, 2016

New Whitepaper: Elements of a Regulatory Inspection

While inspections of studies with pending marketing applications are considered routine, FDA has recently shifted its focus toward an early intervention paradigm. Under this design, BIMO Inspections can occur prior to trial completion. This approach allows FDA the opportunity to affect proactive change and continuously improve clinical investigator compliance. Early intervention inspections can be challenging to predict as the audits are not necessarily triggered by a sponsor regulatory submission.

Topics: IMARC Whitepaper, FDA Inspection, BIMO

Posted by John Lehmann on Tue, Aug 25, 2015

Trust the Process – A Case Study

Merriam Webster defines a case study as a published report about a person, group, or situation that has been studied over time; also : a situation in real life that can be looked at or studied to learn about something.  Case studies can be useful to help highlight how to handle a particular situation, including the eventual outcome.

Topics: FDA Audit, FDA Inspection, BIMO

Posted by John Lehmann on Wed, Mar 04, 2015

Trust the Process – A Case Study

Merriam Webster defines a case study as a published report about a person, group, or situation that has been studied over time; also : a situation in real life that can be looked at or studied to learn about something.  Case studies can be useful to help highlight how to handle a particular situation, including the eventual outcome.

Topics: FDA, IMARC Research, BIMO, Audits, Case Study

Posted by Emily Haglund on Wed, Mar 04, 2015

Inspection Ready: Are you Ready for an Inspection Tomorrow?

Recently, a clinical site received a call from an inspector on a Thursday notifying the site of a not-for-cause inspection the following Monday. This was a short gap of time between the notification and actual audit conduct. How can sites make sure they are ready if an inspector calls today?

Topics: BIMO, Auditing, Inspection Ready, Sites

Posted by Mary Lewis on Mon, Nov 06, 2017

Can Improving Quality in Device Trials Shorten Time to Market?

A medical device company files a marketing application with FDA and awaits a determination on whether or not its clinical trial data is sufficient to support product approval and/or clearance. 

Modern companies cannot operate today without a quality system and if they are sponsoring clinical research, oversight of clinical studies should fall under their quality system. CDRH conducts on the order of 300 Bioresearch Monitoring (BIMO) inspections per year and annually publishes details of its inspectional findings in medical device trials.

Topics: BIMO, Quality Improvement, Medical Device Trials

Posted by Sandra Maddock on Wed, Mar 04, 2015

Can Improving Quality in Device Trials Shorten Time to Market?

A medical device company files a marketing application with FDA and awaits a determination on whether or not its clinical trial data is sufficient to support product approval and/or clearance.

Topics: Quality in Device Trials, Shorten Time to Market, BIMO

requestconsult-bg.jpg
Clinical Research Training Requirements
Featured Resource

clinical research Training requirements

This whitepaper examines the similarities and differences between various US and international regulations and place them within the context of any number of roles found within the realm of clinical research.